The White House yesterday gave the U.S. Centers for Medicare & Medicaid Services the go-ahead to publish its proposed remedy [...] …
Category: Federal
Apexus, the federally contracted 340B prime vendor, and AIDS Healthcare Foundation are meeting with a mediator to try to settle [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The latest guidance to implement first-time drug price negotiation under Medicare said federal officials still are looking for a process [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
U.S. Sen Bill Cassidy (La.), the top Republican on the Senate Health, Education, Labor, and Pensions Committee, said in an [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The national health center group promoting 340C—a proposed alternative to the 340B drug pricing program for health centers, federal grantees, [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The National Rural Health Association has intensified its 340B advocacy work with a new congressional campaign and set of policy [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A bill amending the 340B statute to explicitly require drug makers to unconditionally sell and deliver 340B drugs dispensed by contract pharmacies is expected to be introduced just before or during the 340B Coalition summer conference July 10-12 near Washington,
…
Two hospital groups separately urged Biden administration officials this month to not divert funding from non-340B hospitals and some 340B hospitals in order to repay other 340B hospitals for almost five years’ worth of illegal Medicare Part B drug payment
…
Federal health care officials can’t make a South Carolina health center obey their reading of the 340B patient definition for the same reason a federal appeals court said in January that the officials can’t force drug manufacturers to deliver 340B
…
Drug industry trade group Pharmaceutical Research and Manufacturers of America and drug manufacturer Bristol Myers Squibb have filed separate federal lawsuits to stop Medicare from negotiating the prices of some drugs, charging that it would impose unconstitutional price controls on
…